{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T23:35:33Z","timestamp":1786318533762,"version":"build-2736575974"},"reference-count":45,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["LGBT Health"],"published-print":{"date-parts":[[2024,9,1]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>The human papillomavirus (HPV) causes cervicovaginal, oral, and anogenital cancer, and cervical cancer screening options include HPV testing of a clinician-collected sample. Transgender and gender diverse (TGD) people assigned female at birth (AFAB) face many barriers to preventive care, including cancer screening. Self-sampling options may increase access and participation in HPV testing and cancer screening. This study estimated the prevalence of HPV in self-collected cervicovaginal, oral, and anal samples from Midwestern TGD individuals AFAB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We recruited TGD individuals AFAB for an observational study, mailing them materials to self-collect cervicovaginal, oral, and anal samples at home. We tested samples for high-risk (HR; 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59) and other HPV genotypes (6, 11, 66, 68, 73, 90) using a polymerase chain reaction mass array test. Prevalence ratios for HPV infection at each site as a function of participant characteristics were estimated in log-binomial models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Out of 137 consenting participants, 102 completed sample collection. Among those with valid tests, 8.8% (HR\u2009=\u20096.6%; HPV 16\/18\u2009=\u20093.3%) were positive for oral HPV, 30.5% (HR\u2009=\u200926.8%; HPV 16\/18\u2009=\u20099.7%) for cervicovaginal HPV, and 39.6% (HR\u2009=\u200933.3%; HPV 16\/18\u2009=\u20098.3%) for anal HPV. A larger fraction of oral (71.4%) than anal infections (50.0%) were concordant with a cervicovaginal infection of the same type.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>We detected HR cervicovaginal, oral, and anal HPV in TGD people AFAB. It is essential that we reduce barriers to cancer screening for TGD populations, such as through the development of a clinically approved self-screening HPV test.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/lgbt.2023.0335","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T09:16:53Z","timestamp":1711444613000},"page":"437-445","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":6,"title":["Prevalence and Determinants of Cervicovaginal, Oral, and Anal Human Papillomavirus Infection in a Population of Transgender and Gender Diverse People Assigned Female at Birth"],"prefix":"10.1177","volume":"11","author":[{"given":"Ryan D.","family":"McIntosh","sequence":"first","affiliation":[{"name":"Department of Epidemiology, University of Michigan, Ann Arbor, Michigan, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily C.","family":"Andrus","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Michigan, Ann Arbor, Michigan, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather M.","family":"Walline","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, University of Michigan, Ann Arbor, Michigan, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire B.","family":"Sandler","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Michigan, Ann Arbor, Michigan, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Goudsmit","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, University of Michigan, Ann Arbor, Michigan, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly B.","family":"Moravek","sequence":"additional","affiliation":[{"name":"Reproductive Endocrinology Clinic, Center for Reproductive Medicine, University of Michigan, Ann Arbor, Michigan, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphna","family":"Stroumsa","sequence":"additional","affiliation":[{"name":"Reproductive Endocrinology Clinic, Center for Reproductive Medicine, University of Michigan, Ann Arbor, Michigan, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3489-7058","authenticated-orcid":false,"given":"Shanna K.","family":"Kattari","sequence":"additional","affiliation":[{"name":"School of Social Work, University of Michigan, Ann Arbor, Michigan, USA."},{"name":"Department of Women's and Gender Studies, University of Michigan, Ann Arbor, Michigan, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3779-5287","authenticated-orcid":false,"given":"Andrew F.","family":"Brouwer","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, University of Michigan, Ann Arbor, Michigan, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,9,5]]},"reference":[{"key":"e_1_3_6_2_2","unstructured":"Centers for Disease Control and Prevention. Cancers associated with human papillomavirus United States 2011 to 2015. United States Cancer Statistics Data Brief No. 4. Centers for Disease Control and Prevention: Atlanta GA; 2018."},{"key":"e_1_3_6_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.10897"},{"key":"e_1_3_6_4_2","doi-asserted-by":"publisher","DOI":"10.1080\/17441692.2015.1134613"},{"key":"e_1_3_6_5_2","doi-asserted-by":"publisher","DOI":"10.1080\/13691058.2016.1177203"},{"key":"e_1_3_6_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-013-2753-1"},{"key":"e_1_3_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nwh.2017.12.008"},{"key":"e_1_3_6_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13669-017-0204-4"},{"key":"e_1_3_6_9_2","doi-asserted-by":"publisher","DOI":"10.1089\/lgbt.2016.0143"},{"key":"e_1_3_6_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-015-3462-8"},{"key":"e_1_3_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2014.07.031"},{"key":"e_1_3_6_12_2","doi-asserted-by":"publisher","DOI":"10.1177\/1557988320925691"},{"key":"e_1_3_6_13_2","doi-asserted-by":"publisher","DOI":"10.1080\/23293691.2022.2094737"},{"key":"e_1_3_6_14_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190172"},{"key":"e_1_3_6_15_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2539-x"},{"key":"e_1_3_6_16_2","doi-asserted-by":"publisher","DOI":"10.1089\/lgbt.2016.0187"},{"key":"e_1_3_6_17_2","doi-asserted-by":"publisher","DOI":"10.1089\/lgbt.2019.0202"},{"key":"e_1_3_6_18_2","doi-asserted-by":"publisher","DOI":"10.1089\/lgbt.2016.0142"},{"key":"e_1_3_6_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djs491"},{"key":"e_1_3_6_20_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21442"},{"key":"e_1_3_6_21_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6733a2"},{"key":"e_1_3_6_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit799"},{"key":"e_1_3_6_23_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1314-0"},{"key":"e_1_3_6_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2016.0064"},{"key":"e_1_3_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mbs.2015.10.012"},{"key":"e_1_3_6_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix116"},{"key":"e_1_3_6_27_2","doi-asserted-by":"publisher","DOI":"10.7326\/M17-1363"},{"key":"e_1_3_6_28_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139524"},{"key":"e_1_3_6_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2014-051955"},{"key":"e_1_3_6_30_2","unstructured":"Rovers Medical Devices. Evalyn\u00ae Brush. Oss the Netherlands; 2022. Available from: www.roversmedicaldevices.com\/cell-sampling-devices\/evalyn-brush\/ [Last accessed: September12 2023]."},{"key":"e_1_3_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pvr.2018.04.005"},{"key":"e_1_3_6_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw232"},{"key":"e_1_3_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70096-8"},{"key":"e_1_3_6_34_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-021618"},{"key":"e_1_3_6_35_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2013.5460"},{"key":"e_1_3_6_36_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0268104"},{"key":"e_1_3_6_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2019.03.040"},{"key":"e_1_3_6_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2015.03.034"},{"key":"e_1_3_6_39_2","article-title":"Cervicovaginal and anal self-sampling for HPV testing in a transgender and gender diverse population assigned female at birth: Comfort, difficulty, and willingness to use","author":"Welsh EF","unstructured":"Welsh EF, , Andrus EC, , Sandler CB, et al. Cervicovaginal and anal self-sampling for HPV testing in a transgender and gender diverse population assigned female at birth: Comfort, difficulty, and willingness to use. [Preprint] medRxiv 2023.08.15.23294132; doi: 10.1101\/2023.08.15.23294132","journal-title":"medRxiv"},{"key":"e_1_3_6_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000000159"},{"key":"e_1_3_6_41_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e31824f1c65"},{"key":"e_1_3_6_42_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-056502"},{"key":"e_1_3_6_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e318269d098"},{"key":"e_1_3_6_44_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086023"},{"key":"e_1_3_6_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw063"},{"key":"e_1_3_6_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2013.09.003"}],"container-title":["LGBT Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/lgbt.2023.0335","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/lgbt.2023.0335","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/lgbt.2023.0335","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:06:29Z","timestamp":1777665989000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/lgbt.2023.0335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,1]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,9,1]]}},"alternative-id":["10.1089\/lgbt.2023.0335"],"URL":"https:\/\/doi.org\/10.1089\/lgbt.2023.0335","relation":{},"ISSN":["2325-8292","2325-8306"],"issn-type":[{"value":"2325-8292","type":"print"},{"value":"2325-8306","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,1]]}}}